Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1959 1
1964 1
1970 1
2003 1
2004 3
2005 1
2006 3
2008 2
2009 2
2010 1
2013 2
2014 6
2015 6
2016 4
2017 2
2018 7
2019 7
2020 5
2021 11
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

66 results
Results by year
Filters applied: . Clear all
Page 1
Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection.
De Giorgi V, West KA, Henning AN, Chen LN, Holbrook MR, Gross R, Liang J, Postnikova E, Trenbeath J, Pogue S, Scinto T, Alter HJ, Cantilena CC. De Giorgi V, et al. Among authors: postnikova e. J Infect Dis. 2021 Oct 28;224(8):1294-1304. doi: 10.1093/infdis/jiab295. J Infect Dis. 2021. PMID: 34089610 Free PMC article.
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern.
Cho H, Gonzales-Wartz KK, Huang D, Yuan M, Peterson M, Liang J, Beutler N, Torres JL, Cong Y, Postnikova E, Bangaru S, Talana CA, Shi W, Yang ES, Zhang Y, Leung K, Wang L, Peng L, Skinner J, Li S, Wu NC, Liu H, Dacon C, Moyer T, Cohen M, Zhao M, Lee FE, Weinberg RS, Douagi I, Gross R, Schmaljohn C, Pegu A, Mascola JR, Holbrook M, Nemazee D, Rogers TF, Ward AB, Wilson IA, Crompton PD, Tan J. Cho H, et al. Among authors: postnikova e. Sci Transl Med. 2021 Oct 20;13(616):eabj5413. doi: 10.1126/scitranslmed.abj5413. Epub 2021 Oct 20. Sci Transl Med. 2021. PMID: 34519517
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates.
Boonyaratanakornkit J, Morishima C, Selke S, Zamora D, McGuffin S, Shapiro AE, Campbell VL, McClurkan CL, Jing L, Gross R, Liang J, Postnikova E, Mazur S, Lukin VV, Chaudhary A, Das MK, Fink SL, Bryan A, Greninger AL, Jerome KR, Holbrook MR, Gernsheimer TB, Wener MH, Wald A, Koelle DM. Boonyaratanakornkit J, et al. Among authors: postnikova e. J Clin Invest. 2021 Feb 1;131(3):e144930. doi: 10.1172/JCI144930. J Clin Invest. 2021. PMID: 33320842 Free PMC article. Clinical Trial.
On-Demand Patient-Specific Phenotype-to-Genotype Ebola Virus Characterization.
Beitzel BF, Radoshitzky SR, Di Paola N, Brannan JM, Kimmel D, Caviness K, Soloveva V, Yu S, Postnikova EN, Finch CL, Liu H, Prugar L, Bakken R, Dye JM, Kugelman JR, Cunningham JM, Sanchez-Lockhart M, Kuhn JH, Palacios G. Beitzel BF, et al. Among authors: postnikova en. Viruses. 2021 Oct 6;13(10):2010. doi: 10.3390/v13102010. Viruses. 2021. PMID: 34696439 Free PMC article.
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants.
Cho H, Gonzales-Wartz KK, Huang D, Yuan M, Peterson M, Liang J, Beutler N, Torres JL, Cong Y, Postnikova E, Bangaru S, Talana CA, Shi W, Yang ES, Zhang Y, Leung K, Wang L, Peng L, Skinner J, Li S, Wu NC, Liu H, Dacon C, Moyer T, Cohen M, Zhao M, Lee FE, Weinberg RS, Douagi I, Gross R, Schmaljohn C, Pegu A, Mascola JR, Holbrook M, Nemazee D, Rogers TF, Ward AB, Wilson IA, Crompton PD, Tan J. Cho H, et al. Among authors: postnikova e. bioRxiv. 2021 Apr 1:2021.04.01.437942. doi: 10.1101/2021.04.01.437942. Preprint. bioRxiv. 2021. PMID: 33821267 Free PMC article. Updated.
Anti-SARS-CoV-2 Serology persistence over time in COVID-19 Convalescent Plasma Donors.
De Giorgi V, West KA, Henning AN, Chen L, Holbrook MR, Gross R, Liang J, Postnikova E, Trenbeath J, Pogue S, Scinto T, Alter HJ, Cantilena CC. De Giorgi V, et al. Among authors: postnikova e. medRxiv. 2021 Mar 10:2021.03.08.21253093. doi: 10.1101/2021.03.08.21253093. Preprint. medRxiv. 2021. PMID: 33758897 Free PMC article.
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.
Wirnsberger G, Monteil V, Eaton B, Postnikova E, Murphy M, Braunsfeld B, Crozier I, Kricek F, Niederhöfer J, Schwarzböck A, Breid H, Sanchez Jimenez A, Bugajska-Schretter A, Dohnal A, Ruf C, Gugenberger R, Hagelkruys A, Montserrat N, Holbrook MR, Oostenbrink C, Shoemaker RH, Mirazimi A, Penninger JM. Wirnsberger G, et al. Among authors: postnikova e. bioRxiv. 2021 Sep 10:2021.09.10.459744. doi: 10.1101/2021.09.10.459744. Preprint. bioRxiv. 2021. PMID: 34545368 Free PMC article.
Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples.
Bennett RS, Postnikova EN, Liang J, Gross R, Mazur S, Dixit S, Lukin VV, Kocher G, Yu S, Georgia-Clark S, Gerhardt D, Cai Y, Marron L, Holbrook MR. Bennett RS, et al. Among authors: postnikova en. bioRxiv. 2021 Mar 5:2021.03.05.434152. doi: 10.1101/2021.03.05.434152. Preprint. bioRxiv. 2021. PMID: 33688658 Free PMC article. Updated.
In Vivo Activity of Amodiaquine against Ebola Virus Infection.
DeWald LE, Johnson JC, Gerhardt DM, Torzewski LM, Postnikova E, Honko AN, Janosko K, Huzella L, Dowling WE, Eakin AE, Osborn BL, Gahagen J, Tang L, Green CE, Mirsalis JC, Holbrook MR, Jahrling PB, Dyall J, Hensley LE. DeWald LE, et al. Among authors: postnikova e. Sci Rep. 2019 Dec 27;9(1):20199. doi: 10.1038/s41598-019-56481-0. Sci Rep. 2019. PMID: 31882748 Free PMC article.
66 results